# Study to Evaluate the Safety of Rotarix™ in Chinese Children

> **NCT01086436** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 50 (actual)

## Conditions studied

- Infections, Rotavirus

## Interventions

- **BIOLOGICAL:** Rotarix ™
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01086436
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03-13
- **Primary completion:** 2010-04-16
- **Final completion:** 2010-04-16
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01086436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01086436, "Study to Evaluate the Safety of Rotarix™ in Chinese Children". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT01086436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*